Leadership Overview
Artivion has 4 executives leading key functions including corporate strategy, financial operations, clinical research, and medical oversight.
Focused on advancing aortic disease treatment, Artivion delivers high-quality cardiac and vascular devices to surgeons globally while maintaining a commitment to improving patient outcomes through innovative, life-saving medical technologies.
Focused on advancing aortic disease treatment, Artivion delivers high-quality cardiac and vascular devices to surgeons globally while maintaining a commitment to improving patient outcomes through innovative, life-saving medical technologies.
Leadership Roles at Artivion
J. Mackin - Chairman, President & Chief Executive Officer
J. Mackin, the Chairman, President & Chief Executive Officer at Artivion, directs the overarching corporate strategy for the global medical technology firm. Overseeing the development and distribution of aortic disease solutions, the Chairman, President & Chief Executive Officer ensures alignment between manufacturing capabilities and clinical needs. This leadership role involves managing relationships with the Board and driving long-term growth across international markets. By prioritizing the expansion of the cardiac and vascular device portfolio, J. Mackin secures the company's position as a leader in surgical innovation. The Chairman, President & Chief Executive Officer maintains a focus on operational excellence, ensuring that every product line meets rigorous quality standards. Through consistent engagement with global surgical partners, the executive fosters an environment of continuous improvement. Ultimately, the Chairman, President & Chief Executive Officer drives the strategic vision necessary to address complex aortic conditions while delivering value to stakeholders and patients worldwide.
Lance Berry - Executive Vice President & Chief Operating Officer & Chief Financial Officer
Lance Berry, the Executive Vice President & Chief Operating Officer & Chief Financial Officer at Artivion, manages the financial health and operational infrastructure of the organization. Overseeing the manufacturing and supply chain logistics, the Executive Vice President & Chief Operating Officer & Chief Financial Officer ensures that production cycles meet the high demand for surgical sealants and stent grafts. This leadership role involves optimizing capital allocation to support research and development initiatives. By streamlining internal processes, Lance Berry enhances the efficiency of global distribution networks. The Executive Vice President & Chief Operating Officer & Chief Financial Officer monitors fiscal performance, providing the necessary resources for the company to scale its medical technology offerings. Through rigorous financial planning and operational oversight, the executive supports the broader mission of treating aortic disease. Ultimately, the Executive Vice President & Chief Operating Officer & Chief Financial Officer maintains the fiscal stability required to sustain long-term innovation and market expansion.
Simona Zannetti - Senior VP, Clinical Research & Chief Medical Officer
Simona Zannetti, the Senior VP, Clinical Research & Chief Medical Officer at Artivion, leads the scientific validation and clinical trial processes for new cardiac and vascular devices. Overseeing the rigorous testing of implantable tissues and heart valves, the Senior VP, Clinical Research & Chief Medical Officer ensures that all products adhere to strict safety and efficacy standards. This leadership role involves collaborating with regulatory bodies and surgical experts to advance the treatment of aortic disease. By managing complex clinical research programs, Simona Zannetti drives the evidence-based development of high-quality medical technologies. The Senior VP, Clinical Research & Chief Medical Officer evaluates emerging data to refine product performance and patient outcomes. Through strategic oversight of clinical initiatives, the executive bridges the gap between laboratory innovation and real-world surgical application. Ultimately, the Senior VP, Clinical Research & Chief Medical Officer secures the scientific integrity of the company's portfolio, ensuring that every solution provides tangible benefits to patients.
Marshall Stanton - Senior Chief Medical Officer, Vice President , Clinical Research
Marshall Stanton, the Senior Chief Medical Officer, Vice President , Clinical Research at Artivion, directs the medical strategy and clinical research initiatives focused on aortic disease treatment. Overseeing the integration of advanced surgical sealants and stent grafts into clinical practice, the Senior Chief Medical Officer, Vice President , Clinical Research ensures that surgeons receive the necessary support for complex procedures. This leadership role involves analyzing clinical outcomes to inform future product design and innovation. By managing the research pipeline, Marshall Stanton facilitates the transition of new technologies from development to market adoption. The Senior Chief Medical Officer, Vice President , Clinical Research maintains close ties with the medical community to identify unmet needs in vascular care. Through the coordination of clinical studies, the executive validates the performance of the company's cardiac devices. Ultimately, the Senior Chief Medical Officer, Vice President , Clinical Research drives the clinical excellence required to improve patient outcomes across global markets.
Explore Leadership Teams in Manufacturing
Healthium Medtech operates as a global medical technology organization dedicated to designing, manufacturing, and delivering a broad range of healthcare products that support surgical, post-surgical, and chronic care needs. The company focuses on developing precision-driven medical solutions that enhance clinical outcomes while improving accessibility to high-quality healthcare products across diverse markets. Its operational philosophy is rooted in the belief that medical technology should be both effective and widely available, enabling healthcare professionals to provide better care to patients across various clinical settings. The organization’s portfolio encompasses multiple categories within the medical technology domain, including advanced surgical consumables, wound care solutions, arthroscopy products, and infection prevention systems. These offerings are designed to support healthcare providers throughout the patient care continuum, from surgical intervention to recovery and long-term management. By maintaining a comprehensive product range, the company ensures that it can address a wide spectrum of clinical requirements while maintaining consistency in quality and performance.
Company Leadership MA
SD
VV
Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. The company is headquartered in Charenton-le-Pont, France.
Company Leadership TT
AJ
KL
AS
Poly Medicure Limited, widely recognized under the Polymed brand, is a globally established medical device manufacturing company specializing in the development, production, and distribution of high-quality healthcare consumables and medical technologies. Headquartered in New Delhi, India, the organization has become one of the most prominent medical device manufacturers originating from India and has established a strong international footprint across healthcare markets worldwide. The company primarily operates within the medical technology and healthcare manufacturing sector, focusing on products that support hospitals, healthcare professionals, diagnostic centers, and patient care environments. The organization was founded with a vision to improve healthcare accessibility through innovative and reliable medical technologies. Since commencing manufacturing operations during the mid-nineteen nineties, the company has expanded from a small manufacturing operation into a globally recognized medical technology enterprise serving healthcare systems across numerous countries. The company’s growth has been driven by its strong emphasis on product innovation, advanced manufacturing capabilities, operational quality standards, and international expansion initiatives.
Company Leadership RG
NV
Founded in 1976 and headquartered in Warwick, Rhode Island, CME Corp is a medical equipment distributor.
Company Leadership
PW
MC
Frequently Asked Questions Regarding Artivion Top Executives and Leadership Team
Unlock more people and company data
